Literature DB >> 9834343

Interleukin-10 reduces circulating levels of serum cytokines in experimental pancreatitis.

A J Rongione1, A M Kusske, H A Reber, S W Ashley, D W McFadden.   

Abstract

Over the past few years, evidence has accumulated that implicates proinflammatory cytokines as the mediators responsible for the escalation of acute pancreatitis into a multisystem disease. It has been shown that the degree of serum cytokine elevation, particularly the macrophage-derived cytokines interleukin-1, interleukin-6, and tumor necrosis factor-alpha, correlates with the severity and outcome of acute pancreatitis. Interleukin-10 is an anti-inflammatory cytokine that inhibits cytokine production from the macrophage. The aim of this study was to determine whether interleukin-10 would decrease both the severity of acute pancreatitis and the level of circulating proinflammatory cytokines. Ninety female mice were divided into three equal groups. Group 1 (controls) received intraperitoneal saline solution. Groups 2 and 3 received intraperitoneal cerulein (50 mg/kg/hr) for 7 hours. In addition, group 3 was given 1500 units of intraperitoneal interleukin-10, beginning 1 hour after the induction of acute pancreatitis and every 3 hours thereafter. Animals were killed at 3-hour intervals. Blood samples were obtained for serum amylase and cytokine determinations (interleukin-1beta, interleukin-6, and tumor necrosis factor-alpha). Pancreata were dissected free and fixed in formalin for blinded histologic scoring. Interleukin-10 reduced the serum levels of interleukin-1beta, interleukin-6, tumor necrosis factor-alpha, and amylase in comparison to untreated animals with pancreatitis (P < 0.05). Pancreatic edema, necrosis, and inflammatory cell infiltrate were also reduced in those animals given interleukin-10 (P <0.05). Histologic score, serum cytokines, and amylase levels are elevated during acute pancreatitis. Interleukin-10 given therapeutically, that is, after the onset of acute pancreatitis, lessened the severity of disease, probably through inhibition of the macrophage. This was associated with a decrease in circulating cytokine levels.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9834343     DOI: 10.1016/s1091-255x(97)80104-7

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  22 in total

Review 1.  The biology of interleukin-6.

Authors:  T Kishimoto
Journal:  Blood       Date:  1989-07       Impact factor: 22.113

Review 2.  Interleukin 1: the first interleukin.

Authors:  F S di Giovine; G W Duff
Journal:  Immunol Today       Date:  1990-01

3.  Caerulein-induced acute necrotizing pancreatitis in mice: protective effects of proglumide, benzotript, and secretin.

Authors:  C Niederau; L D Ferrell; J H Grendell
Journal:  Gastroenterology       Date:  1985-05       Impact factor: 22.682

4.  IL-10 inhibits cytokine production, vascular leakage, and swelling during T helper 1 cell-induced delayed-type hypersensitivity.

Authors:  L Li; J F Elliott; T R Mosmann
Journal:  J Immunol       Date:  1994-11-01       Impact factor: 5.422

5.  Inhibition of TNF alpha improves survival in an experimental model of acute pancreatitis.

Authors:  C B Hughes; L W Gaber; A B Mohey el-Din; H P Grewal; M Kotb; L Mann; A O Gaber
Journal:  Am Surg       Date:  1996-01       Impact factor: 0.688

6.  Acute pancreatitis induces intrapancreatic tumor necrosis factor gene expression.

Authors:  J G Norman; G W Fink; M G Franz
Journal:  Arch Surg       Date:  1995-09

7.  Interleukin-1 receptor antagonist decreases severity of experimental acute pancreatitis.

Authors:  J Norman; M Franz; J Messina; A Riker; P J Fabri; A S Rosemurgy; W R Gower
Journal:  Surgery       Date:  1995-06       Impact factor: 3.982

8.  Role of interleukin-6 in mediating the acute phase protein response and potential as an early means of severity assessment in acute pancreatitis.

Authors:  D I Heath; A Cruickshank; M Gudgeon; A Jehanli; A Shenkin; C W Imrie
Journal:  Gut       Date:  1993-01       Impact factor: 23.059

9.  Antibodies to cachectin/tumor necrosis factor reduce interleukin 1 beta and interleukin 6 appearance during lethal bacteremia.

Authors:  Y Fong; K J Tracey; L L Moldawer; D G Hesse; K B Manogue; J S Kenney; A T Lee; G C Kuo; A C Allison; S F Lowry
Journal:  J Exp Med       Date:  1989-11-01       Impact factor: 14.307

10.  Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes.

Authors:  R de Waal Malefyt; J Abrams; B Bennett; C G Figdor; J E de Vries
Journal:  J Exp Med       Date:  1991-11-01       Impact factor: 14.307

View more
  11 in total

1.  Immunomodulation in surgical practice.

Authors:  R Andersson; B Andersson; E Andersson; G Eckerwall; M Nordén; B Tingstedt
Journal:  HPB (Oxford)       Date:  2006       Impact factor: 3.647

2.  Early-phase peritoneal drainage and lavage in a rat model of severe acute pancreatitis.

Authors:  Leiming Zhu; Jilin Lu; Jing Yang; Peng Sun
Journal:  Surg Today       Date:  2015-04-21       Impact factor: 2.549

3.  The effect of interleukin-6 on bacterial translocation in acute canine pancreatitis.

Authors:  Q Liu; G Djuricin; C Nathan; P Gattuso; R A Weinstein; R A Prinz
Journal:  Int J Pancreatol       Date:  2000-04

4.  Association of polymorphisms of IL and CD14 genes with acute severe pancreatitis and septic shock.

Authors:  Dian-Liang Zhang; Hong-Mei Zheng; Bao-Jun Yu; Zhi-Wei Jiang; Jie-Shou Li
Journal:  World J Gastroenterol       Date:  2005-07-28       Impact factor: 5.742

Review 5.  Sensory nerves and pancreatitis.

Authors:  Qingfu Li; Jie Peng
Journal:  Gland Surg       Date:  2014-11

6.  Effects of trimetazidine in acute pancreatitis induced by L-arginine.

Authors:  Akan Yenicerioglu; Ziya Cetinkaya; Mustafa Girgin; Bilal Ustundag; Ibrahim H Ozercan; Refik Ayten; Burhan H Kanat
Journal:  Can J Surg       Date:  2013-06       Impact factor: 2.089

Review 7.  Pharmacological approach to acute pancreatitis.

Authors:  Ulrich-Christian Bang; Synne Semb; Camilla Nojgaard; Flemming Bendtsen
Journal:  World J Gastroenterol       Date:  2008-05-21       Impact factor: 5.742

Review 8.  Treatment of acute pancreatitis: focus on medical care.

Authors:  Roland Andersson; Anna Swärd; Bobby Tingstedt; Daniel Akerberg
Journal:  Drugs       Date:  2009       Impact factor: 9.546

9.  Transient human gene therapy: a novel cytokine regulatory strategy for experimental pancreatitis.

Authors:  W Denham; D Denham; J Yang; G Carter; S MacKay; L L Moldawer; L C Carey; J Norman
Journal:  Ann Surg       Date:  1998-06       Impact factor: 12.969

Review 10.  Pathogenic mechanisms of pancreatitis.

Authors:  Murli Manohar; Alok Kumar Verma; Sathisha Upparahalli Venkateshaiah; Nathan L Sanders; Anil Mishra
Journal:  World J Gastrointest Pharmacol Ther       Date:  2017-02-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.